医护专业人员对大麻产品的态度、知识和信心。

IF 4.1 Q1 PHARMACOLOGY & PHARMACY
Emilio Russo, Paula Martinez Agredano, Peter Flachenecker, Charlotte Lawthom, Duncan Munro, Chandni Hindocha, Makarand Bagul, Eugen Trinka
{"title":"医护专业人员对大麻产品的态度、知识和信心。","authors":"Emilio Russo, Paula Martinez Agredano, Peter Flachenecker, Charlotte Lawthom, Duncan Munro, Chandni Hindocha, Makarand Bagul, Eugen Trinka","doi":"10.1186/s42238-024-00242-y","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Use of cannabis-based products is becoming more frequent, and it is important that healthcare professionals are informed and confident about them when making evidence-based decisions about their use. This study aimed to gain an international perspective on the attitudes, knowledge, and confidence of healthcare professionals about cannabis-based products.</p><p><strong>Methods: </strong>An online questionnaire regarding these products was completed by 1580 healthcare professionals (neurologists, psychiatrists, general practitioners, pharmacists and nurses) from 16 countries across Asia, Europe, Oceania, South America, and the Middle East.</p><p><strong>Results: </strong>Respondents expressed a high level of interest in cannabis-based products (median score 9 out of 10) and reported that they felt knowledgeable about them (median score 6 out of 7). They reported a high level of confidence when providing patients with information on cannabis-based products, returning median scores of 6 and 5 out of 7 for their legality and regulations, and their benefits and risks, respectively. Despite this, healthcare professionals sought further information on cannabis-based products across areas including legality, neurobiology, and scientific evidence. Finally, 59% (n = 930) of respondents considered robust clinical trial evidence as the most important factor to ensure patient safety in the context of these products. Few nominally significant differences emerged between healthcare professionals from different specialities or regions.</p><p><strong>Conclusion: </strong>In conclusion, this large survey of attitudes held by healthcare professionals towards cannabis-based products revealed a high level of interest and a demand for more information. Limitations of this study include potential sample bias and limited external validity.</p>","PeriodicalId":101310,"journal":{"name":"Journal of cannabis research","volume":"6 1","pages":"32"},"PeriodicalIF":4.1000,"publicationDate":"2024-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11267914/pdf/","citationCount":"0","resultStr":"{\"title\":\"The attitudes, knowledge and confidence of healthcare professionals about cannabis-based products.\",\"authors\":\"Emilio Russo, Paula Martinez Agredano, Peter Flachenecker, Charlotte Lawthom, Duncan Munro, Chandni Hindocha, Makarand Bagul, Eugen Trinka\",\"doi\":\"10.1186/s42238-024-00242-y\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Use of cannabis-based products is becoming more frequent, and it is important that healthcare professionals are informed and confident about them when making evidence-based decisions about their use. This study aimed to gain an international perspective on the attitudes, knowledge, and confidence of healthcare professionals about cannabis-based products.</p><p><strong>Methods: </strong>An online questionnaire regarding these products was completed by 1580 healthcare professionals (neurologists, psychiatrists, general practitioners, pharmacists and nurses) from 16 countries across Asia, Europe, Oceania, South America, and the Middle East.</p><p><strong>Results: </strong>Respondents expressed a high level of interest in cannabis-based products (median score 9 out of 10) and reported that they felt knowledgeable about them (median score 6 out of 7). They reported a high level of confidence when providing patients with information on cannabis-based products, returning median scores of 6 and 5 out of 7 for their legality and regulations, and their benefits and risks, respectively. Despite this, healthcare professionals sought further information on cannabis-based products across areas including legality, neurobiology, and scientific evidence. Finally, 59% (n = 930) of respondents considered robust clinical trial evidence as the most important factor to ensure patient safety in the context of these products. Few nominally significant differences emerged between healthcare professionals from different specialities or regions.</p><p><strong>Conclusion: </strong>In conclusion, this large survey of attitudes held by healthcare professionals towards cannabis-based products revealed a high level of interest and a demand for more information. Limitations of this study include potential sample bias and limited external validity.</p>\",\"PeriodicalId\":101310,\"journal\":{\"name\":\"Journal of cannabis research\",\"volume\":\"6 1\",\"pages\":\"32\"},\"PeriodicalIF\":4.1000,\"publicationDate\":\"2024-07-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11267914/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of cannabis research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/s42238-024-00242-y\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cannabis research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s42238-024-00242-y","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

背景:大麻制品的使用日益频繁,医护专业人员在对其使用做出循证决策时,必须对大麻制品有所了解并充满信心。本研究旨在从国际视角了解医疗保健专业人员对大麻制品的态度、知识和信心:来自亚洲、欧洲、大洋洲、南美洲和中东 16 个国家的 1580 名医疗保健专业人员(神经科医生、精神科医生、全科医生、药剂师和护士)填写了一份有关这些产品的在线问卷:受访者对大麻产品表现出高度兴趣(中位数为 9 分,满分为 10 分),并表示他们对大麻产品有所了解(中位数为 6 分,满分为 7 分)。他们表示在向病人提供大麻产品信息时信心十足,在大麻产品的合法性和法规及其益处和风险方面的中位数分别为 6 分和 5 分(满分 7 分)。尽管如此,医护专业人员仍希望进一步了解大麻制品在合法性、神经生物学和科学证据等方面的信息。最后,59%(n = 930)的受访者认为,在这些产品方面,可靠的临床试验证据是确保患者安全的最重要因素。来自不同专业或地区的医疗保健专业人员之间几乎没有明显的差异:总之,这项关于医疗保健专业人员对大麻产品态度的大型调查显示,他们对大麻产品的兴趣很高,并要求获得更多信息。这项研究的局限性包括潜在的样本偏差和有限的外部有效性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The attitudes, knowledge and confidence of healthcare professionals about cannabis-based products.

Background: Use of cannabis-based products is becoming more frequent, and it is important that healthcare professionals are informed and confident about them when making evidence-based decisions about their use. This study aimed to gain an international perspective on the attitudes, knowledge, and confidence of healthcare professionals about cannabis-based products.

Methods: An online questionnaire regarding these products was completed by 1580 healthcare professionals (neurologists, psychiatrists, general practitioners, pharmacists and nurses) from 16 countries across Asia, Europe, Oceania, South America, and the Middle East.

Results: Respondents expressed a high level of interest in cannabis-based products (median score 9 out of 10) and reported that they felt knowledgeable about them (median score 6 out of 7). They reported a high level of confidence when providing patients with information on cannabis-based products, returning median scores of 6 and 5 out of 7 for their legality and regulations, and their benefits and risks, respectively. Despite this, healthcare professionals sought further information on cannabis-based products across areas including legality, neurobiology, and scientific evidence. Finally, 59% (n = 930) of respondents considered robust clinical trial evidence as the most important factor to ensure patient safety in the context of these products. Few nominally significant differences emerged between healthcare professionals from different specialities or regions.

Conclusion: In conclusion, this large survey of attitudes held by healthcare professionals towards cannabis-based products revealed a high level of interest and a demand for more information. Limitations of this study include potential sample bias and limited external validity.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
6.20
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信